Since p53 mutations result in gain-of-function as an oncogene as well as loss-of-function in terms of tumor suppressor function, targeting mtp53 or restoring wild-type p53 (wtp53) is a promising therapeutic option [239]. Here, TP53 is linked to neoplasm.